vs
Clipper Realty Inc.（CLPR）与ARS Pharmaceuticals, Inc.（SPRY）财务数据对比。点击上方公司名可切换其他公司
Clipper Realty Inc.的季度营收约是ARS Pharmaceuticals, Inc.的1.3倍（$37.1M vs $28.1M），Clipper Realty Inc.净利率更高（-30.4% vs -147.1%，领先116.7%），Clipper Realty Inc.同比增速更快（-2.6% vs -67.6%）
Clipper Realty Inc.旗下Clipper Equity由大卫·比斯特里瑟和山姆·莱文森牵头成立，在美国纽约与新泽西州拥有超60栋物业，合计数千套住宅单元。该企业最为人熟知的事迹是曾在2007年2月出价13亿美元收购纽约布鲁克林的斯塔雷特城住宅区，该交易曾是当时全球规模最大的房地产交易之一。
ARS Pharmaceuticals是一家处于后期研发阶段的生物制药企业，专注于开发和商业化严重过敏反应创新疗法，核心产品为无需注射的肾上腺素鼻腔递送制剂，主要面向北美市场，服务存在致命过敏风险的成人及儿童患者群体。
CLPR vs SPRY — 直观对比
营收规模更大
CLPR
是对方的1.3倍
$28.1M
营收增速更快
CLPR
高出65.0%
-67.6%
净利率更高
CLPR
高出116.7%
-147.1%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $37.1M | $28.1M |
| 净利润 | $-11.3M | $-41.3M |
| 毛利率 | -5.2% | — |
| 营业利润率 | 21.8% | -147.6% |
| 净利率 | -30.4% | -147.1% |
| 营收同比 | -2.6% | -67.6% |
| 净利润同比 | -938.6% | -182.8% |
| 每股收益（稀释后） | — | $-0.41 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CLPRSPRY
| Q4 25 | $37.1M | $28.1M | ||
| Q3 25 | $37.7M | $32.5M | ||
| Q2 25 | $39.0M | $15.7M | ||
| Q1 25 | $39.4M | $8.0M | ||
| Q4 24 | $38.0M | $86.6M | ||
| Q3 24 | $37.6M | $2.1M | ||
| Q2 24 | $37.3M | $500.0K | ||
| Q1 24 | $35.8M | $0 |
净利润CLPRSPRY
| Q4 25 | $-11.3M | $-41.3M | ||
| Q3 25 | $-4.6M | $-51.2M | ||
| Q2 25 | $-1.4M | $-44.9M | ||
| Q1 25 | $-35.1M | $-33.9M | ||
| Q4 24 | $-1.1M | $49.9M | ||
| Q3 24 | $-1.1M | $-19.1M | ||
| Q2 24 | $-1.7M | $-12.5M | ||
| Q1 24 | $-2.7M | $-10.3M |
毛利率CLPRSPRY
| Q4 25 | -5.2% | — | ||
| Q3 25 | 23.6% | — | ||
| Q2 25 | 27.8% | — | ||
| Q1 25 | -34.5% | — | ||
| Q4 24 | 28.8% | — | ||
| Q3 24 | 28.6% | — | ||
| Q2 24 | 26.8% | — | ||
| Q1 24 | 25.4% | — |
营业利润率CLPRSPRY
| Q4 25 | 21.8% | -147.6% | ||
| Q3 25 | 23.6% | -163.7% | ||
| Q2 25 | 27.7% | -302.9% | ||
| Q1 25 | -59.9% | -466.3% | ||
| Q4 24 | 28.1% | 54.5% | ||
| Q3 24 | 28.6% | -1051.6% | ||
| Q2 24 | 26.8% | -3068.0% | ||
| Q1 24 | 25.4% | — |
净利率CLPRSPRY
| Q4 25 | -30.4% | -147.1% | ||
| Q3 25 | -12.2% | -157.4% | ||
| Q2 25 | -3.5% | -285.6% | ||
| Q1 25 | -89.1% | -425.7% | ||
| Q4 24 | -2.9% | 57.7% | ||
| Q3 24 | -2.9% | -925.0% | ||
| Q2 24 | -4.7% | -2503.2% | ||
| Q1 24 | -7.5% | — |
每股收益（稀释后）CLPRSPRY
| Q4 25 | — | $-0.41 | ||
| Q3 25 | — | $-0.52 | ||
| Q2 25 | — | $-0.46 | ||
| Q1 25 | — | $-0.35 | ||
| Q4 24 | — | $0.52 | ||
| Q3 24 | — | $-0.20 | ||
| Q2 24 | — | $-0.13 | ||
| Q1 24 | — | $-0.11 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $30.8M | $245.0M |
| 总债务越低越好 | — | $96.4M |
| 股东权益账面价值 | $-30.7M | $114.3M |
| 总资产 | $1.2B | $327.7M |
| 负债/权益比越低杠杆越低 | — | 0.84× |
8季度趋势，按日历期对齐
现金及短期投资CLPRSPRY
| Q4 25 | $30.8M | $245.0M | ||
| Q3 25 | $26.1M | $288.2M | ||
| Q2 25 | $32.0M | $240.1M | ||
| Q1 25 | $21.3M | $275.7M | ||
| Q4 24 | $19.9M | $314.0M | ||
| Q3 24 | $18.6M | $204.6M | ||
| Q2 24 | $20.3M | $218.7M | ||
| Q1 24 | $21.9M | $223.6M |
总债务CLPRSPRY
| Q4 25 | — | $96.4M | ||
| Q3 25 | — | $96.2M | ||
| Q2 25 | — | — | ||
| Q1 25 | $1.3B | — | ||
| Q4 24 | $1.3B | $0 | ||
| Q3 24 | $1.3B | — | ||
| Q2 24 | $1.2B | — | ||
| Q1 24 | $1.2B | — |
股东权益CLPRSPRY
| Q4 25 | $-30.7M | $114.3M | ||
| Q3 25 | $-25.0M | $147.7M | ||
| Q2 25 | $-21.9M | $192.3M | ||
| Q1 25 | $-20.1M | $229.0M | ||
| Q4 24 | $-5.4M | $256.8M | ||
| Q3 24 | $-3.6M | $201.0M | ||
| Q2 24 | $-1.8M | $215.2M | ||
| Q1 24 | $279.0K | $223.9M |
总资产CLPRSPRY
| Q4 25 | $1.2B | $327.7M | ||
| Q3 25 | $1.2B | $372.8M | ||
| Q2 25 | $1.2B | $313.5M | ||
| Q1 25 | $1.3B | $327.3M | ||
| Q4 24 | $1.3B | $351.2M | ||
| Q3 24 | $1.3B | $217.6M | ||
| Q2 24 | $1.3B | $222.0M | ||
| Q1 24 | $1.3B | $227.6M |
负债/权益比CLPRSPRY
| Q4 25 | — | 0.84× | ||
| Q3 25 | — | 0.65× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.00× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 4396.73× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $22.6M | $-43.5M |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | 0.0% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流CLPRSPRY
| Q4 25 | $22.6M | $-43.5M | ||
| Q3 25 | $1.4M | $-47.0M | ||
| Q2 25 | $8.4M | $-39.6M | ||
| Q1 25 | $6.7M | $-40.7M | ||
| Q4 24 | $31.9M | $42.0M | ||
| Q3 24 | $6.3M | $-14.5M | ||
| Q2 24 | $8.8M | $-7.3M | ||
| Q1 24 | $6.3M | $-6.7M |
自由现金流CLPRSPRY
| Q4 25 | — | — | ||
| Q3 25 | — | $-47.2M | ||
| Q2 25 | — | $-39.6M | ||
| Q1 25 | $-4.6M | $-40.8M | ||
| Q4 24 | $-37.9M | $41.7M | ||
| Q3 24 | — | $-14.6M | ||
| Q2 24 | — | $-7.3M | ||
| Q1 24 | $-14.7M | $-6.8M |
自由现金流率CLPRSPRY
| Q4 25 | — | — | ||
| Q3 25 | — | -145.4% | ||
| Q2 25 | — | -252.2% | ||
| Q1 25 | -11.7% | -512.1% | ||
| Q4 24 | -99.5% | 48.2% | ||
| Q3 24 | — | -706.3% | ||
| Q2 24 | — | -1463.4% | ||
| Q1 24 | -41.1% | — |
资本支出强度CLPRSPRY
| Q4 25 | — | 0.0% | ||
| Q3 25 | — | 0.6% | ||
| Q2 25 | — | 0.3% | ||
| Q1 25 | 28.6% | 1.1% | ||
| Q4 24 | 183.3% | 0.3% | ||
| Q3 24 | — | 6.8% | ||
| Q2 24 | — | 7.6% | ||
| Q1 24 | 58.6% | — |
现金转化率CLPRSPRY
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.84× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CLPR
| Residential Segment | $30.8M | 83% |
| Commercial Real Estate | $6.2M | 17% |
SPRY
| Products | $20.3M | 72% |
| Other | $7.8M | 28% |
